🟢 Vera Therapeutics is trading 4.42% up today; move remains unattributed

Vera Therapeutics is trading 4.42% up at $35.77, with today’s move unattributed.

• On September 15, TRUTAKNA met all prespecified ORIGIN 3 endpoints.
• Vera planned a supplemental FDA filing in Q4 2026; the broader market is modestly positive, but no clear September 22, 2026 company-specific catalyst was identified.